Skip to content

RoosterBio

Site Navigation

  • Our Technology
    • Foundation for Multiple Therapeutics
    • Powerful Technology
    • Built-In Manufacturing Process
  • Products
    • High Volume hMSCs
      • XF hBM-MSCs
      • XF hUC-MSCs
      • XF RTP hBM-MSCs
      • Traditional hBM-MSCs
      • Traditional RTP hBM-MSCs
    • hMSC Bioprocess Media
      • XF hMSC Bioprocess Media
      • XF hMSC Bioreactor Feeds
      • XF hMSC Bioprocess Supplements & Reagents
      • Traditional hMSC Bioprocess Media
    • CliniControl Products
      • CliniControl High Volume hMSCs
      • CliniControl hMSC Bioprocess Media
      • CliniControl Extracellular Vesicle (EV) Production
    • Extracellular Vesicle (EV) Production
      • EV Collection Media
      • EV Supplements & Reagents
    • hMSC Kits
      • RoosterVial & RoosterNourish Test Kits
      • Donor Screening Test Kits
      • Bioreactor Starter Kits
      • Bioreactor Development Kits
      • Bioprinting Kits
      • Bioprinting RTP Kits
  • Services
    • Process Development Services
  • Knowledge Center
    • Resources
    • Blog Articles
    • Publications
  • About Us
    • Why RoosterBio?
    • Our Leadership
    • Our Collaborators
    • Our Culture
    • Careers
  • News & Events
    • News
    • Events
    • Press Releases
    • Media Kit
  • Contact Us

RoosterBio Blog

Patient Treatment
April 29, 2020 Cell Therapy, COVID-19

Accelerating COVID-19 Treatments with Patient Safety As First Priority

Patient Safety as First Priority in COVID-19 Treatment The medical and scientific communities are ardently working on promising new treatments for COVID-19. With the urgency to treat patients currently affected ... More

COVID-19 Revs Up
April 24, 2020 Cell Therapy, COVID-19, MSCs & Characterization

The Race to Beat COVID-19 with hMSCs Revs Up

Industry sponsored MSC-based clinical trial activities for COVID-19 As of this writing, more than a dozen companies and groups have announced their interests to develop mesenchymal stromal/stem cell (MSC) based ... More

Crawl Walk Run
April 14, 2020 BioEconomy, Cell Therapy, COVID-19, MSCs & Characterization

Patience for hMSCs in COVID-19: We Must Crawl Before We Run

“If you can’t fly then run, if you can’t run then walk, if you can’t walk then crawl, but whatever you do you have to keep moving forward.” ― Martin ... More

ARDS
April 03, 2020 Cell Therapy, COVID-19, EVs & Exosomes, MSCs & Characterization

hMSCs: A Secret(ome) Weapon Against ARDS

Authored by Mayasari Lim, PhD, Jonathan Carson, PhD, and Jon A. Rowley, PhD, RoosterBio, Inc. Some research suggests that ARDS might be treatable with the secretome of MSCs. Scientists and ... More

Sidebar Navigation

  • BioEconomy
  • Biomanufacturing
  • Bioprinting & Biofabrication
  • Bioprocess Tools
  • Cell Therapy
  • Conference Highlights
  • Corporate
  • COVID-19
  • EVs & Exosomes
  • MSCs & Characterization
  • Quality & Regulatory
  • Tissue Engineering
#1 Most Popular Blogs 3D Culture Adipose MSCs Adult Stem Cells Animal Serum BioEconomy Biomanufacturing Biomaterials Bioprinting / Biofabrication Bioprocess Bioreactors Bone Marrow MSCs Cancer Cell Therapy Clinical Trials COVID-19 Critical Trauma Democratizing Technology Extracellular Vesicles / Exosomes Fetal Bovine Serum GMP Manufacturing hUC-MSC Mesenchymal Stem / Stromal Cells Regenerative Medicine Regulatory RoosterBio Standardization Tissue Engineering Umbilical Cord MSCs Warfighter Wound Care

Careers

Contact Us

Contact Information

RoosterBio, Inc.
Email: info@roosterbio.com Phone: +1 301-200-5366

Share

  • Twitter
  • Facebook
  • YouTube
  • LinkedIn
  • Email

Copyright © 2021 RoosterBio, Inc. All Rights Reserved / Privacy Policy / Website design by Wood Street, Inc.